News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
1 (252)
2 (183)
3 (155)
4 (168)
5 (197)
8 (242)
9 (206)
10 (139)
11 (156)
12 (132)
15 (169)
16 (170)
17 (165)
18 (176)
19 (125)
22 (163)
23 (114)
24 (65)
29 (72)
30 (72)
31 (50)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
29
30
31
Drug Development
Janssen Research & Development Release: IMBRUVICA (ibrutinib) Shows Sustained Progression-Free Survival In Patients With High-Risk Chronic Lymphocytic Leukemia With Genetic Mutation
December 9, 2014
·
14 min read
Drug Development
Janssen Research & Development Release: IMBRUVICA (ibrutinib) Long-term Follow-up Data In Patients Living With Relapsed/Refractory Mantle Cell Lymphoma Show Almost Half Alive At Two Years
December 9, 2014
·
14 min read
Pharm Country
TrialScope’s Latest Version Of PharmaCM Supports European Clinical Trial Results Reporting
December 9, 2014
·
2 min read
Business
Arcturus Therapeutics Announces The Appointment Of Michael R. Hodges, M.D. To The Scientific Advisory Board
December 9, 2014
·
3 min read
Policy
Cohera Medical, Inc. Submits Investigational Device Exemption To FDA For Clinical Trial Of Its Sylys Surgical Sealant
December 9, 2014
·
4 min read
BioMidwest
DePuy Synthes Companies Release: New National Survey Reveals The Surprising Overall Life Impact Of Joint Pain - It’s More Than Physical
December 9, 2014
·
4 min read
Policy
U.S. FDA Grants CLIA Waiver For Alere Determine HIV-1/2 Ag/Ab Combo Test
December 9, 2014
·
3 min read
Drug Development
Can-Fite BioPharma To Initiate The Development Program Of Its Next Generation Drug Cf602
December 9, 2014
·
4 min read
Drug Development
ContraVir Pharmaceuticals Initiates Pharmacokinetic Study Of Lead Antiviral FV-100 For Treating Shingles
December 9, 2014
·
4 min read
FDA
Nektar Therapeutics (CA) Release: MOVENTIG Approved In The European Union For Opioid-Induced Constipation
December 9, 2014
·
3 min read
Previous
8 of 21
Next
